The Latest Cardiac and Vascular News
− Full Study Enrollment Completed Well Ahead of Schedule − CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has achieved full patient enrollment in its HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of cardiomyopathy in patients […]
First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair performed by Professor Marek Jasinski at the Wroclaw Medical University AUSTIN, Texas–(BUSINESS WIRE)–BioStable Science & Engineering, Inc. announced today that the first commercial implantations of its HAART 200 Aortic Annuloplasty Device were performed on Monday, August 2nd by Professor […]
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/dJwHD Controlling […]
BANGALORE, India, Aug. 6, 2021 /PRNewswire/ — Columbia Asia Referral Hospitals Yeshwanthpur (A Unit of Manipal Hospitals), today announced the launch of a new Cath Lab unit to highlight and demonstrate the importance of ‘Door-to-Balloon’ time during cardiac emergencies. Anand Hedge (name changed), a 56-year-old gentleman was working at his factory when he suffered a […]
LOS ANGELES, Aug. 4, 2021 /PRNewswire/ — Today, Abcentra LLC announced that the first patients have been dosed in its multi-center phase 2 trial assessing the safety and activity of orticumab in patients with moderate-to-severe plaque psoriasis and cardiometabolic risk factors. Orticumab is a fully-human monoclonal antibody against a specific oxidized low-density lipoprotein (LDL) epitope. Seventeen […]
Findings could potentially widen use for overweight adults who are high risk for heart disease CLEVELAND – A clinical trial led by Dr. Ian Neeland with University Hospitals Harrington Heart & Vascular Institute could have implications for overweight and obese adults who may benefit from reducing intra-abdominal fat. The […]
– Ionis-discovered pelacarsen continues to advance as potential first new therapy for Lp(a)-driven cardiovascular disease CARLSBAD, Calif., Aug. 2, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that pelacarsen, formerly known as AKCEA-APO(a)-LRx, and licensed by Novartis (NYSE: NVS) for exclusive worldwide development and commercialization, continues to advance in the clinic as the potential […]
TORONTO, July 29, 2021 /PRNewswire/ – Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution. The new solution includes the world’s first 3-in-1 RF wire paired with a seamless shapeable dilator designed to optimize tissue dilation for large sheath procedures, including left atrial appendage closure, transvenous mitral […]
BiovitalsHF® Approved for Expedited FDA Review Process as a First-in-Class DTx for Heart Failure that Augments Traditional Guideline-Directed Medical Therapy BOSTON, July 29, 2021 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device […]
Cohere Health adds care-pathway-based cardiology solution to its transformative digital prior authorization product line BOSTON, July 28, 2021 /PRNewswire/ — Cohere Health, an emerging high-growth digital health company, today announced a new solution for health plans in partnership with the American College of Cardiology (ACC) that actively engages physicians, patients, health plans and […]
